Overview / Abstract: |
Based solely on clinical evaluation, the diagnosis of migraine can be challenging for clinicians. Its management typically requires lifestyle and trigger management, along with acute, preventive, or combination treatments. Recent migraine research has focused on the role of calcitonin gene-related peptide (CGRP), which is released in significant amounts during an acute attack and is chronically elevated in patients with chronic migraine. The development of novel medications targeting the CGRP pathway could offer an effective option for patients with acute and chronic migraine. Primary care providers, including residents and fellows, will play an increasingly important role in identifying patients with migraine headache and ensuring they are properly diagnosed and appropriately treated. This CME activity will provide these clinicians with the latest evidence-based strategies and emerging therapies for migraine management. EDUCATIONAL OBJECTIVES - At the conclusion of this activity, participants should be able to demonstrate the ability to: - Examine the epidemiology, differential diagnosis, and impact of migraine within the primary-care patient population |
Expiration |
Dec 19, 2019 |
Discipline(s) |
Physician CME |
Credits / Hours |
1.00 AMA PRA Category 1 Credit™ |
Accreditation |
Jointly provided by the Potomac Center for Medical Education and Rockpointe |
Presenters / Authors / Faculty |
M. Susan Burke, MD, FACP Jack Schim, MD Christopher Damiano, DO, MPH Matthew Delmonico, DO |
Sponsors / Supporters / Grant Providers |
This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding, please visit www.lillygrantoffice.com. |
Keywords / Search Terms |
Rockpointe Migraine, Migraines, Migraine Treatment, Migraine Management, Chronic Migraine, Pain Management, Headache, Headaches, Head Pain, Migraine Pain, Chronic Pain, CME, Courses, Continuing Medical Education, Primary Care Free CE CME |